Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for CRSP

Stock Name	Crispr Therapeutics AG
Ticker	CRSP(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	CH0334081137
LEI	506700O6IRRIQLT3W370

Show aggregate CRSP holdings

News associated with CRSP

Look Under The Hood: IYY Has 10% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-12 08:04:40
Mitsubishi UFJ Asset Management Co. Ltd. Purchases 473 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP): Mitsubishi UFJ Asset Management Co. Ltd. raised its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,725 shares of the company’s stock after buying an additional 473 […] - 2025-08-15 04:46:59
Sum Up The Parts: ESML Could Be Worth $50: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-12 08:44:07
Arkadios Wealth Advisors Has $382,000 Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP): Arkadios Wealth Advisors decreased its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 7.6% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 11,238 shares of the company’s stock after selling 923 shares during the period. Arkadios Wealth Advisors’ holdings in CRISPR Therapeutics […] - 2025-08-06 06:46:57
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Purchased by Envestnet Asset Management Inc.: Envestnet Asset Management Inc. boosted its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 21.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 68,058 shares of the company’s stock after acquiring an additional 12,025 shares during the period. Envestnet […] - 2025-07-29 04:09:03
Bank of New York Mellon Corp Boosts Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP): Bank of New York Mellon Corp increased its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 1.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,702 shares of the company’s stock after acquiring an additional 1,133 shares during […] - 2025-07-28 04:22:49
Private Advisor Group LLC Increases Stake in CRISPR Therapeutics AG (NASDAQ:CRSP): Private Advisor Group LLC increased its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 27.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 108,418 shares of the company’s stock after buying an additional 23,382 shares during the quarter. […] - 2025-07-23 06:23:04
3 Monster Stocks in the Making to Buy Right Now: Key PointsCRISPR Therapeutics is still in its early growth stage. - 2025-07-21 01:07:00
3 Monster Stocks to Hold for the Next 10 Years: Key PointsOnline video game platform Roblox is different from any other platform. - 2025-07-17 06:51:00
Allworth Financial LP Has $393,000 Position in CRISPR Therapeutics AG (NASDAQ:CRSP): Allworth Financial LP lowered its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 23.3% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 11,560 shares of the company’s stock after selling 3,518 shares during the quarter. Allworth Financial LP’s holdings […] - 2025-07-15 06:16:47
CRISPR Therapeutics AG (NASDAQ:CRSP) Stake Lifted by Axxcess Wealth Management LLC: Axxcess Wealth Management LLC increased its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 4.0% in the first quarter, Holdings Channel.com reports. The institutional investor owned 10,309 shares of the company’s stock after acquiring an additional 393 shares during the period. Axxcess Wealth Management LLC’s holdings in CRISPR Therapeutics were worth […] - 2025-07-14 05:45:01
Traders Purchase Large Volume of Call Options on CRISPR Therapeutics (NASDAQ:CRSP): CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) was the recipient of some unusual options trading on Wednesday. Stock investors bought 10,886 call options on the company. This represents an increase of approximately 49% compared to the typical daily volume of 7,308 call options. CRISPR Therapeutics Trading Down 1.8% NASDAQ CRSP opened at $59.00 on […] - 2025-07-11 02:50:55
CRISPR Therapeutics (NASDAQ:CRSP) Given “Buy” Rating at Needham & Company LLC: CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports. They presently have a $81.00 target price on the stock. Needham & Company LLC’s price objective would suggest a potential upside of 34.82% from the stock’s […] - 2025-07-10 04:01:25
Vontobel Holding Ltd. Trims Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP): Vontobel Holding Ltd. lessened its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 15.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 12,741 shares of the company’s stock after selling 2,327 shares during the quarter. Vontobel Holding Ltd.’s holdings […] - 2025-07-08 05:21:04
Spire Wealth Management Has $57,000 Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP): Spire Wealth Management reduced its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 15.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,670 shares of the company’s stock after selling 300 shares during the period. Spire Wealth Management’s […] - 2025-07-02 04:46:55
CRISPR Therapeutics AG (NASDAQ:CRSP) Receives $69.53 Average Target Price from Analysts: Shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) have earned a consensus recommendation of “Hold” from the seventeen brokerages that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and nine have issued a buy recommendation on the company. […] - 2025-06-24 02:54:46
CRISPR Therapeutics AG (NASDAQ:CRSP) Shares Bought by Farther Finance Advisors LLC: Farther Finance Advisors LLC lifted its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 46.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,626 shares of the company’s stock after purchasing an additional 1,792 […] - 2025-06-20 04:29:03
Analysts Expect JHSC To Hit $45: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-10 08:53:42
California State Teachers Retirement System Sells 689 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP): California State Teachers Retirement System lowered its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 1.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 69,742 shares of the company’s stock after selling 689 shares during the period. California State […] - 2025-06-06 05:06:55
The Best Stocks to Invest $1,000 in Right Now: Are you just as afraid of a market pullback right now as you are of missing out on upside? If so, you're not alone. This is a confusing environment for investors. Major names like Nvidia and Home Depot are sending mixed messages, while the market itself seems to be waiting for mo - 2025-06-03 05:30:00
Two Sigma Advisers LP Increases Position in CRISPR Therapeutics AG (NASDAQ:CRSP): Two Sigma Advisers LP lifted its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 50.4% during the 4th quarter, Holdings Channel.com reports. The fund owned 84,800 shares of the company’s stock after acquiring an additional 28,400 shares during the period. Two Sigma Advisers LP’s holdings in CRISPR Therapeutics were worth $3,338,000 as of […] - 2025-05-27 05:30:57
CRISPR Therapeutics AG (NASDAQ:CRSP) Given Consensus Recommendation of “Moderate Buy” by Analysts: CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eighteen ratings firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, seven have assigned a hold recommendation and ten have assigned a buy recommendation […] - 2025-05-27 03:06:46
Ameriprise Financial Inc. Has $8.07 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP): Ameriprise Financial Inc. lifted its position in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.9% in the fourth quarter, HoldingsChannel.com reports. The firm owned 205,173 shares of the company’s stock after acquiring an additional 18,412 shares during the period. Ameriprise Financial Inc.’s holdings in CRISPR Therapeutics were worth $8,072,000 as of its most recent […] - 2025-05-22 04:35:07
5 Monster Stocks to Hold for the Next 10 Years: The professionals who manage Wall Street funds and cater to wealthy investors live and die by their quarterly performance. However, the individual investor can win the long game by focusing on what will matter the most years into the future. - 2025-05-20 05:30:00
BNP Paribas Financial Markets Has $3.27 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP): BNP Paribas Financial Markets decreased its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 5.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 82,994 shares of the company’s stock after selling 4,962 shares during the quarter. BNP […] - 2025-05-16 05:08:54
CRISPR Therapeutics AG (NASDAQ:CRSP) Stake Decreased by Mercer Global Advisors Inc. ADV: Mercer Global Advisors Inc. ADV lessened its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 13.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 9,980 shares of the company’s stock after selling 1,598 shares during […] - 2025-05-15 05:10:56
Barclays Cuts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $42.00: CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its price target lowered by Barclays from $56.00 to $42.00 in a research report sent to investors on Friday morning,Benzinga reports. The firm currently has an equal weight rating on the stock. Several other equities analysts have also recently commented on the stock. Truist Financial boosted their price […] - 2025-05-12 05:46:49
3 Monster Stocks to Hold for the Next 10 Years: The best investments are often stocks of companies offering goods and services that are perpetually in demand. Think entertainment, healthcare, or more recently, some consumer technologies. Many of these stocks can be bought and held forever, since they dish out reasonably predic - 2025-05-10 06:12:00
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought: Growth stocks have been rallying in recent weeks, and that's usually great news for Cathie Wood. The founder, CEO, and stock-picking ace of the Ark Invest family of exchange-traded funds (ETFs) has momentum on her side. Her largest fund has soared nearly 30% since bottoming out l - 2025-05-08 12:22:00
Dimensional Fund Advisors LP Has $37.28 Million Stake in CRISPR Therapeutics AG (NASDAQ:CRSP): Dimensional Fund Advisors LP boosted its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 14.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 947,301 shares of the company’s stock after purchasing an additional 122,695 shares during the quarter. Dimensional […] - 2025-05-05 05:20:52

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc CRSP holdings

Date	Number of CRSP Shares Held	Base Market Value of CRSP Shares	Local Market Value of CRSP Shares	Change in CRSP Shares Held	Change in CRSP Base Value	Current Price per CRSP Share Held	Previous Price per CRSP Share Held
2025-09-29 (Monday)	24,532	USD 1,564,406	USD 1,564,406
2025-09-26 (Friday)	24,532	USD 1,512,888	USD 1,512,888
2025-09-25 (Thursday)	24,532	USD 1,479,770	USD 1,479,770	0	USD -17,909	USD 60.32	USD 61.05
2025-09-24 (Wednesday)	24,532	USD 1,497,679	USD 1,497,679
2025-09-17 (Wednesday)	24,374	USD 1,439,772	USD 1,439,772	0	USD -51,673	USD 59.07	USD 61.19
2025-09-16 (Tuesday)	24,374	USD 1,491,445	USD 1,491,445
2025-09-12 (Friday)	24,216	USD 1,362,392	USD 1,362,392

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of CRSP by Blackrock for IE00B3VWM098

Show aggregate share trades of CRSP

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-08-21 SELL -49 52.820* 44.38 Profit of 2,175 on sale
2025-07-31 BUY 147 56.260* 44.25
2025-06-30 SELL -98 48.640* 42.56 Profit of 4,171 on sale
2025-06-25 SELL -49 47.660* 42.46 Profit of 2,080 on sale
2025-06-20 SELL -98 44.250* 42.39 Profit of 4,155 on sale
2025-05-30 BUY 4,992 36.290* 42.58
2025-05-23 BUY 31 36.860* 42.81
2025-05-19 SELL -31 38.680* 42.97 Profit of 1,332 on sale
2025-05-15 SELL -93 36.310* 43.07 Profit of 4,005 on sale
2025-05-12 SELL -31 37.590* 43.24 Profit of 1,340 on sale
2025-05-09 SELL -31 35.620* 43.31 Profit of 1,342 on sale
2025-04-30 SELL -31 38.670* 43.76 Profit of 1,357 on sale
2025-04-24 SELL -62 39.110* 43.99 Profit of 2,727 on sale
2025-04-17 SELL -31 37.770* 44.30 Profit of 1,373 on sale
2025-04-15 SELL -93 38.950* 44.43 Profit of 4,132 on sale
2025-04-14 SELL -93 38.810* 44.49 Profit of 4,137 on sale
2025-04-09 SELL -124 34.890* 44.77 Profit of 5,552 on sale
2025-04-07 SELL -217 32.380* 45.07 Profit of 9,781 on sale
2025-04-04 SELL -310 32.650* 45.22 Profit of 14,018 on sale
2025-03-31 BUY 31 34.030* 45.64
2025-03-19 SELL -62 41.940* 46.22 Profit of 2,866 on sale
2025-03-14 SELL -186 42.120* 46.40 Profit of 8,630 on sale
2025-03-13 SELL -62 41.990* 46.46 Profit of 2,881 on sale
2025-03-12 SELL -1,054 43.490* 46.51 Profit of 49,017 on sale
2025-03-07 SELL -62 45.530* 46.63 Profit of 2,891 on sale
2025-03-06 SELL -93 43.310* 46.68 Profit of 4,341 on sale
2025-03-03 SELL -31 42.290* 46.85 Profit of 1,452 on sale
2025-02-28 SELL -186 43.920* 46.90 Profit of 8,723 on sale
2025-02-26 SELL -31 44.400* 47.00 Profit of 1,457 on sale
2025-02-25 SELL -93 44.510* 47.04 Profit of 4,375 on sale
2025-02-18 BUY 155 52.220* 46.76
2025-02-13 BUY 31 43.490* 46.70
2025-02-12 BUY 31 43.300* 46.77
2025-02-11 BUY 93 39.620* 46.92
2025-02-06 BUY 279 40.610* 47.39
2025-01-27 BUY 31 41.850* 48.69
2024-12-30 BUY 155 38.650* 49.50
2024-12-06 BUY 124 52.330* 49.43
2024-12-05 BUY 31 49.510* 49.42
2024-12-04 BUY 155 51.140* 49.36
2024-11-29 BUY 155 51.170* 48.98
2024-11-27 BUY 124 50.840* 48.82
2024-11-26 BUY 31 49.310* 48.80
2024-11-25 SELL -22,938 50.400* 48.72 Profit of 1,117,616 on sale
2024-11-21 BUY 505 46.290* 48.90
2024-11-20 BUY 303 47.260* 48.99
2024-11-18 BUY 1,212 47.300* 49.22
2024-11-12 BUY 808 50.730* 49.12
2024-11-08 BUY 505 51.620* 48.94
2024-11-07 BUY 1,515 51.880* 48.71
2024-11-06 BUY 202 50.720* 48.54
2024-10-31 BUY 101 46.390* 48.05
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-08-21	SELL	-49	52.820*	44.38 Profit of 2,175 on sale
2025-07-31	BUY	147	56.260*	44.25
2025-06-30	SELL	-98	48.640*	42.56 Profit of 4,171 on sale
2025-06-25	SELL	-49	47.660*	42.46 Profit of 2,080 on sale
2025-06-20	SELL	-98	44.250*	42.39 Profit of 4,155 on sale
2025-05-30	BUY	4,992	36.290*	42.58
2025-05-23	BUY	31	36.860*	42.81
2025-05-19	SELL	-31	38.680*	42.97 Profit of 1,332 on sale
2025-05-15	SELL	-93	36.310*	43.07 Profit of 4,005 on sale
2025-05-12	SELL	-31	37.590*	43.24 Profit of 1,340 on sale
2025-05-09	SELL	-31	35.620*	43.31 Profit of 1,342 on sale
2025-04-30	SELL	-31	38.670*	43.76 Profit of 1,357 on sale
2025-04-24	SELL	-62	39.110*	43.99 Profit of 2,727 on sale
2025-04-17	SELL	-31	37.770*	44.30 Profit of 1,373 on sale
2025-04-15	SELL	-93	38.950*	44.43 Profit of 4,132 on sale
2025-04-14	SELL	-93	38.810*	44.49 Profit of 4,137 on sale
2025-04-09	SELL	-124	34.890*	44.77 Profit of 5,552 on sale
2025-04-07	SELL	-217	32.380*	45.07 Profit of 9,781 on sale
2025-04-04	SELL	-310	32.650*	45.22 Profit of 14,018 on sale
2025-03-31	BUY	31	34.030*	45.64
2025-03-19	SELL	-62	41.940*	46.22 Profit of 2,866 on sale
2025-03-14	SELL	-186	42.120*	46.40 Profit of 8,630 on sale
2025-03-13	SELL	-62	41.990*	46.46 Profit of 2,881 on sale
2025-03-12	SELL	-1,054	43.490*	46.51 Profit of 49,017 on sale
2025-03-07	SELL	-62	45.530*	46.63 Profit of 2,891 on sale
2025-03-06	SELL	-93	43.310*	46.68 Profit of 4,341 on sale
2025-03-03	SELL	-31	42.290*	46.85 Profit of 1,452 on sale
2025-02-28	SELL	-186	43.920*	46.90 Profit of 8,723 on sale
2025-02-26	SELL	-31	44.400*	47.00 Profit of 1,457 on sale
2025-02-25	SELL	-93	44.510*	47.04 Profit of 4,375 on sale
2025-02-18	BUY	155	52.220*	46.76
2025-02-13	BUY	31	43.490*	46.70
2025-02-12	BUY	31	43.300*	46.77
2025-02-11	BUY	93	39.620*	46.92
2025-02-06	BUY	279	40.610*	47.39
2025-01-27	BUY	31	41.850*	48.69
2024-12-30	BUY	155	38.650*	49.50
2024-12-06	BUY	124	52.330*	49.43
2024-12-05	BUY	31	49.510*	49.42
2024-12-04	BUY	155	51.140*	49.36
2024-11-29	BUY	155	51.170*	48.98
2024-11-27	BUY	124	50.840*	48.82
2024-11-26	BUY	31	49.310*	48.80
2024-11-25	SELL	-22,938	50.400*	48.72 Profit of 1,117,616 on sale
2024-11-21	BUY	505	46.290*	48.90
2024-11-20	BUY	303	47.260*	48.99
2024-11-18	BUY	1,212	47.300*	49.22
2024-11-12	BUY	808	50.730*	49.12
2024-11-08	BUY	505	51.620*	48.94
2024-11-07	BUY	1,515	51.880*	48.71
2024-11-06	BUY	202	50.720*	48.54
2024-10-31	BUY	101	46.390*	48.05

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of CRSP

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	953,115	4,329	1,561,113	61.1%
2025-09-18	785,585	8,069	1,220,457	64.4%
2025-09-17	969,121	4,953	1,279,724	75.7%
2025-09-16	717,696	9,117	1,297,125	55.3%
2025-09-15	563,632	479	919,636	61.3%
2025-09-12	474,757	434	740,276	64.1%
2025-09-11	514,524	2,730	952,484	54.0%
2025-09-10	332,259	613	508,092	65.4%
2025-09-09	499,735	309	750,774	66.6%
2025-09-08	359,910	19,558	639,197	56.3%
2025-09-05	505,860	3,428	1,468,732	34.4%
2025-09-04	422,391	282	1,377,451	30.7%
2025-09-03	409,382	185	711,844	57.5%
2025-09-02	441,840	754	719,669	61.4%
2025-08-29	356,063	1,032	642,325	55.4%
2025-08-28	384,593	4,175	619,959	62.0%
2025-08-27	474,604	413	707,409	67.1%
2025-08-26	337,801	1,235	504,210	67.0%
2025-08-25	341,566	592	535,909	63.7%
2025-08-22	432,311	1,060	750,307	57.6%
2025-08-21	276,384	525	494,439	55.9%
2025-08-20	481,035	2,447	863,226	55.7%
2025-08-19	927,248	8,194	1,463,449	63.4%
2025-08-18	615,097	9,049	934,759	65.8%
2025-08-15	954,882	10,702	1,464,721	65.2%
2025-08-14	1,089,392	1,036	1,635,553	66.6%
2025-08-13	1,486,679	7,827	2,362,627	62.9%
2025-08-12	691,845	70	906,264	76.3%
2025-08-11	532,884	1,847	848,363	62.8%
2025-08-08	465,426	7,018	715,834	65.0%
2025-08-07	619,867	41,404	892,222	69.5%
2025-08-06	732,619	52,416	1,122,409	65.3%
2025-08-05	1,326,117	68,326	1,979,716	67.0%
2025-08-04	954,133	2,820	1,308,605	72.9%
2025-08-01	942,950	1,553	1,336,174	70.6%
2025-07-31	761,454	2,945	1,160,135	65.6%
2025-07-30	798,189	7,689	1,224,483	65.2%
2025-07-29	1,040,522	8,025	1,845,442	56.4%
2025-07-28	381,215	1,024	710,369	53.7%
2025-07-25	712,035	1,807	1,285,840	55.4%
2025-07-24	895,784	5,505	1,297,746	69.0%
2025-07-23	1,105,981	71,388	1,837,178	60.2%
2025-07-22	1,078,815	8,858	1,753,952	61.5%
2025-07-21	1,982,720	46,367	3,377,746	58.7%
2025-07-18	2,862,091	13,877	5,362,030	53.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE